LENVATINIB + EVEROLIMUS  A powerful treatment for refractory RCC.

LENVATINIB + EVEROLIMUS A powerful treatment for refractory RCC.

User Photo
kidneycancer

3 years
731 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Thomas E Hutson, DO, PharmD FACP
Director, GU Oncology Program, Co-Director, Urologic Cancer Research and Treatment Center, Texas Oncology/ Baylor Sammons Cancer Center, Professor of Medicine, Texas AM College of Medicine presents LENVATINIB + EVEROLIMUS A powerful treatment for refractory RCC at the 2016 annual International Kidney Cancer Symposium.

Up Next Autoplay
>